6505--Ustekinumab or Biosimilar Syringes/Vials
SAM.GOV Due: July 31, 2025 at 07:30 PM UTC
In-Active Solicitation Source Url

Summary

The opportunity titled '6505--Ustekinumab or Biosimilar Syringes/Vials' is a presolicitation notice from the VA National Acquisition Center, indicating the intent to issue a Request for Proposal (RFP) for the procurement of Ustekinumab syringes and vials. This procurement is aimed at providing an uninterrupted supply of these pharmaceutical products to various federal health agencies, including the Department of Veterans Affairs, Department of Defense, and others. Contractors interested in this opportunity should be capable of supplying FDA-approved Ustekinumab or biosimilar products, with a unique NDC number, and must be prepared to meet the specified annual usage requirements. The contract will be awarded to a responsible offeror who can ensure consistent supply and compliance with the outlined specifications.
Description
Updated estimates for line item 3
Entities
VADO
Department of Veterans Affairs
NAICS
325412
Set Aside
None
Place of Performance
Point of Contact
Full Name Email Phone Type
Christopher Carthron [email protected] None primary
Attachments
  • 36E79725R0045_1.docx
  • 36E79725R0045.docx
  • 36E79725R0045+0001.docx
  • 36E79725R0045+0002.docx